Myometrial contractile responsiveness to oxytocin after dexamethasone suppression of circadian uterine activity in pregnant rhesus macaques during late gestation. 1992

C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
Department of Physiology and Pediatrics, School of Medicine, Loma Linda University, CA 92350.

OBJECTIVE This study was designed to determine if dexamethasone alters myometrial responsiveness to oxytocin or oxytocin secretion. METHODS Studies were conducted in rhesus macaques (n = 6), between 144 and 148 days' gestation (term 167 days). The first study was conducted at 9 AM and repeated 36 hours later at 9 PM. At 9 AM the following morning a continuous maternal dexamethasone infusion (15 micrograms/kg/hr given intravenously) was initiated, and the study was repeated at 9 PM, 60 hours later. Four doses of oxytocin (500, 1000, 2000, and 4000 pg/kg/min) were administered as 1-minute pulses every 5 minutes for 30 minutes. The number of contractions per pulse (contraction/pulse ratio) was used to determine differences in myometrial responsiveness. RESULTS Before dexamethasone infusion there was a circadian rhythm in uterine activity with peak contractile events between 8 and 10 PM (p < 0.01), whereas during infusion the rhythm was ablated. At oxytocin dose 1, the 9 AM contraction/pulse ratio (0.3 +/- 0.1) was lower than that for 9 PM (0.6 +/- 0.2) and for 60 hours later (0.6 +/- 0.1) (mean +/- SE, p < 0.05). Similar results were observed at dose 2, whereas no differences in the contraction/pulse ratio were noted at dose 3. Basal plasma oxytocin concentrations were unaffected by dexamethasone treatment, whereas plasma estradiol and cortisol concentrations were reduced compared with control values (p < 0.01). CONCLUSIONS (1) There is a differential sensitivity to oxytocin between morning and evening and (2) the dexamethasone-induced loss of the uterine contractile rhythm is not the result of a loss of myometrial sensitivity to oxytocin or to a suppression of plasma oxytocin concentrations.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
December 1993, American journal of obstetrics and gynecology,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
February 1983, American journal of obstetrics and gynecology,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
December 1987, American journal of obstetrics and gynecology,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
September 1997, American journal of obstetrics and gynecology,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
June 1991, The Journal of clinical endocrinology and metabolism,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
July 1983, American journal of obstetrics and gynecology,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
January 1990, The Journal of clinical endocrinology and metabolism,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
October 1964, American journal of obstetrics and gynecology,
C A Ducsay, and M G Ervin, and K M Kaushal, and T Matsumoto
August 1989, American journal of obstetrics and gynecology,
Copied contents to your clipboard!